Literature DB >> 22807955

DDR2 polymorphisms and mRNA expression in lung cancers of Japanese patients.

Hidefumi Sasaki1, Masayuki Shitara, Keisuke Yokota, Katsuhiro Okuda, Yu Hikosaka, Satoru Moriyama, Motoki Yano, Yoshitaka Fujii.   

Abstract

Discoidin domain receptor 2, DDR2, is a tyrosine kinase receptor for fibrillar collagen that is involved in postnatal development, tissue repair and primary and metastatic cancer progression. Recently, mutations in the DDR2 kinase gene were identified in squamous cell lung cancer from large-scale Sanger sequencing. The present study investigated the DDR2 gene mutations and mRNA expression in surgically treated non-small cell lung cancer (NSCLC) of squamous histology cases. The presence or absence of DDR2 mutations at the kinase and discoidin domain was analyzed by direct sequencing. In this cohort, DDR2 mutations were not observed in the 166 patients with lung cancer, although DDR2 polymorphisms were observed (H136H, n=14) at the discoidin domain. mRNA levels of DDR2 in lung tumor samples and the adjacent normal lung samples were simultaneously analyzed. DDR2 mRNA levels were significantly decreased in tumor samples compared with normal lung samples. However, the DDR2 mRNA levels were elevated in the DDR2 polymorphism cases.

Entities:  

Year:  2012        PMID: 22807955      PMCID: PMC3398371          DOI: 10.3892/ol.2012.684

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  21 in total

Review 1.  Sensing extracellular matrix: an update on discoidin domain receptor function.

Authors:  Wolfgang F Vogel; Rahim Abdulhussein; Caroline E Ford
Journal:  Cell Signal       Date:  2006-02-28       Impact factor: 4.315

2.  Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS).

Authors:  Masahiro Fukuoka; Yi-Long Wu; Sumitra Thongprasert; Patrapim Sunpaweravong; Swan-Swan Leong; Virote Sriuranpong; Tsu-Yi Chao; Kazuhiko Nakagawa; Da-Tong Chu; Nagahiro Saijo; Emma L Duffield; Yuri Rukazenkov; Georgina Speake; Haiyi Jiang; Alison A Armour; Ka-Fai To; James Chih-Hsin Yang; Tony S K Mok
Journal:  J Clin Oncol       Date:  2011-06-13       Impact factor: 44.544

3.  Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability.

Authors:  Iker Badiola; Patricia Villacé; Iratxe Basaldua; Elvira Olaso
Journal:  Oncol Rep       Date:  2011-06-23       Impact factor: 3.906

4.  Somatic mutations of the protein kinase gene family in human lung cancer.

Authors:  Helen Davies; Chris Hunter; Raffaella Smith; Philip Stephens; Chris Greenman; Graham Bignell; Jon Teague; Adam Butler; Sarah Edkins; Claire Stevens; Adrian Parker; Sarah O'Meara; Tim Avis; Syd Barthorpe; Lisa Brackenbury; Gemma Buck; Jody Clements; Jennifer Cole; Ed Dicks; Ken Edwards; Simon Forbes; Matthew Gorton; Kristian Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jonathon Hinton; David Jones; Vivienne Kosmidou; Ross Laman; Richard Lugg; Andrew Menzies; Janet Perry; Robert Petty; Keiran Raine; Rebecca Shepherd; Alexandra Small; Helen Solomon; Yvonne Stephens; Calli Tofts; Jennifer Varian; Anthony Webb; Sofie West; Sara Widaa; Andrew Yates; Francis Brasseur; Colin S Cooper; Adrienne M Flanagan; Anthony Green; Maggie Knowles; Suet Y Leung; Leendert H J Looijenga; Bruce Malkowicz; Marco A Pierotti; Bin T Teh; Siu T Yuen; Sunil R Lakhani; Douglas F Easton; Barbara L Weber; Peter Goldstraw; Andrew G Nicholson; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

5.  EGFR Mutation status in Japanese lung cancer patients: genotyping analysis using LightCycler.

Authors:  Hidefumi Sasaki; Katsuhiko Endo; Akimitsu Konishi; Minoru Takada; Masaaki Kawahara; Keiji Iuchi; Akihide Matsumura; Meinoshin Okumura; Hisaichi Tanaka; Tomoya Kawaguchi; Toshiki Shimizu; Hiroshi Takeuchi; Motoki Yano; Ichiro Fukai; Yoshitaka Fujii
Journal:  Clin Cancer Res       Date:  2005-04-15       Impact factor: 12.531

6.  Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix metalloproteinase-2.

Authors:  Elvira Olaso; Juan-Pablo Labrador; LiHsien Wang; Kazuo Ikeda; Francis J Eng; Rudiger Klein; David H Lovett; Hsin Chieh Lin; Scott L Friedman
Journal:  J Biol Chem       Date:  2001-11-26       Impact factor: 5.157

7.  Overexpression of protein tyrosine kinases in human esophageal cancer.

Authors:  T Nemoto; K Ohashi; T Akashi; J D Johnson; K Hirokawa
Journal:  Pathobiology       Date:  1997       Impact factor: 4.342

8.  Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.

Authors:  Peter S Hammerman; Martin L Sos; Alex H Ramos; Chunxiao Xu; Amit Dutt; Wenjun Zhou; Lear E Brace; Brittany A Woods; Wenchu Lin; Jianming Zhang; Xianming Deng; Sang Min Lim; Stefanie Heynck; Martin Peifer; Jeffrey R Simard; Michael S Lawrence; Robert C Onofrio; Helga B Salvesen; Danila Seidel; Thomas Zander; Johannes M Heuckmann; Alex Soltermann; Holger Moch; Mirjam Koker; Frauke Leenders; Franziska Gabler; Silvia Querings; Sascha Ansén; Elisabeth Brambilla; Christian Brambilla; Philippe Lorimier; Odd Terje Brustugun; Aslaug Helland; Iver Petersen; Joachim H Clement; Harry Groen; Wim Timens; Hannie Sietsma; Erich Stoelben; Jürgen Wolf; David G Beer; Ming Sound Tsao; Megan Hanna; Charles Hatton; Michael J Eck; Pasi A Janne; Bruce E Johnson; Wendy Winckler; Heidi Greulich; Adam J Bass; Jeonghee Cho; Daniel Rauh; Nathanael S Gray; Kwok-Kin Wong; Eric B Haura; Roman K Thomas; Matthew Meyerson
Journal:  Cancer Discov       Date:  2011-06       Impact factor: 39.397

9.  Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer.

Authors:  F Alves; W Vogel; K Mossie; B Millauer; H Höfler; A Ullrich
Journal:  Oncogene       Date:  1995-02-02       Impact factor: 9.867

10.  Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma.

Authors:  C E Ford; S K Lau; C Q Zhu; T Andersson; M S Tsao; W F Vogel
Journal:  Br J Cancer       Date:  2007-02-13       Impact factor: 7.640

View more
  7 in total

1.  Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis.

Authors:  Chenlu Wu; Jiafei Ying; Mei Dai; Jing Peng; Danhua Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-28       Impact factor: 4.322

2.  Assessment of DDR2, BRAF, EGFR and KRAS mutations as therapeutic targets in non-adenocarcinoma lung cancer patients.

Authors:  Hideaki Yashima; Kimihiro Shimizu; Takuya Araki; Tohru Aomori; Yoichi Ohtaki; Toshiteru Nagashima; Yasuaki Enokida; Jun Atsumi; Tomonori Nakamura; Izumi Takeyoshi; Koujirou Yamamoto
Journal:  Mol Clin Oncol       Date:  2014-06-03

Review 3.  Discoidin domain receptor 2 signaling networks and therapy in lung cancer.

Authors:  Leo S Payne; Paul H Huang
Journal:  J Thorac Oncol       Date:  2014-06       Impact factor: 15.609

4.  Prevalence of Mutations in Discoidin Domain-Containing Receptor Tyrosine Kinase 2 (DDR2) in Squamous Cell Lung Cancers in Korean Patients.

Authors:  Mi-Sook Lee; Eun Ah Jung; Sung Bin An; Yu Jin Kim; Doo-Yi Oh; Ji-Young Song; Sang-Won Um; Joungho Han; Yoon-La Choi
Journal:  Cancer Res Treat       Date:  2017-01-25       Impact factor: 4.679

5.  Wrangling phosphoproteomic data to elucidate cancer signaling pathways.

Authors:  Mark L Grimes; Wan-Jui Lee; Laurens van der Maaten; Paul Shannon
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

6.  Identification of novel driver mutations of the discoidin domain receptor 2 (DDR2) gene in squamous cell lung cancer of Chinese patients.

Authors:  Liyun Miao; Yongsheng Wang; Suhua Zhu; Minke Shi; Yan Li; Jingjing Ding; Jun Yang; Qing Ye; Hourong Cai; Deping Zhang; Hongbing Liu; Yong Song
Journal:  BMC Cancer       Date:  2014-05-24       Impact factor: 4.430

Review 7.  Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications.

Authors:  A Quintanal-Villalonga; Luis Paz-Ares; Irene Ferrer; S Molina-Pinelo
Journal:  Dis Markers       Date:  2016-07-26       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.